Clinical Trials for DLBCL - Diffuse Large B Cell Lymphoma

Find clinical trials for dlbcl - diffuse large b cell lymphoma. Discover research opportunities and treatment options in your area.

22 Active Trials Found

Showing 22 trials on this page

Page 1 of 2

P-CD19CD20-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With B Cell Malignancies

NCT ID: NCT06014762

This clinical trial is studying a new treatment called P-CD19CD20-ALLO1, which uses modified immune cells (CAR-T cells) to help fight certain types of blood cancers, specifically different forms of...

Recruiting

Phase: PHASE1 Type: interventional Locations: La Jolla, California, United States, Chapel Hill, North Carolina, United States +10 more

SynKIR-310 for Relapsed/Refractory B-NHL

NCT ID: NCT06544265

The SynKIR-310 trial is a research study aimed at evaluating a new treatment called SynKIR-310 for adults with certain types of B-cell lymphoma that have not responded to previous therapies or have...

Recruiting

Phase: PHASE1 Type: interventional Locations: Fairway, Kansas, United States, Portland, Oregon, United States +1 more

A Phase II Trial of 4 vs 6 Cycles of CHP Combined With Polatuzumab Vedotin-Rituximab in Untreated DLBCL Patients With IPI 0-1

NCT ID: NCT07034508

This clinical trial is studying a new treatment approach for people who have just been diagnosed with a type of blood cancer called diffuse large B-cell lymphoma (DLBCL). Researchers want to find o...

Not yet recruiting

Phase: PHASE2 Type: interventional Locations: Tianjin, , China

Zanubrutinib in Patients With DLBCL and MYD88 or NOTCH1 Mutation or CD5+

NCT ID: NCT06846463

This clinical trial is examining a new treatment called zanubrutinib for patients with a type of cancer known as diffuse large B-cell lymphoma (DLBCL). Specifically, the study is focusing on patien...

Recruiting

Phase: PHASE2 Type: interventional Locations: Richmond, Virginia, United States

A Study of Circulating Tumor DNA (ctDNA) Testing for People With B-Cell Lymphoma

NCT ID: NCT06736613

This clinical trial is studying a specific test called circulating tumor DNA (ctDNA) testing for people with B-cell lymphoma, which is a type of cancer that affects the immune system. The main goal...

Recruiting

Phase: PHASE2 Type: interventional Locations: Basking Ridge, New Jersey, United States, Middletown, New Jersey, United States +5 more

Long-term Study to Evaluate Safety and Persistence of GF-CART01

NCT ID: NCT06985576

This clinical trial is looking at the long-term safety of a treatment called GF-CART01 for patients with certain types of lymphoma, including Diffuse Large B Cell Lymphoma and Follicular Lymphoma. ...

Not yet recruiting

Type: observational Locations: Taipei, , Taiwan

Chidamide Plus R-CHOP in Newly Diagnosed Double-Expressor Diffuse Large B-Cell Lymphoma With Other Molecular Subtypes

NCT ID: NCT06891157

This clinical trial is studying a new treatment approach for adults diagnosed with a type of cancer called diffuse large B-cell lymphoma (DLBCL), specifically those who have a "double-expressor" su...

Recruiting

Phase: PHASE2 Type: interventional Locations: Nanjing, Jiangsu, China

Lenalidomide Combined With G-CHOP in the Treatment of Newly Diagnosed DLBCL With FL

NCT ID: NCT06151080

This clinical trial is studying a new treatment approach for patients newly diagnosed with diffuse large B-cell lymphoma (DLBCL) that also has features of follicular lymphoma (FL). The researchers ...

Recruiting

Phase: PHASE2 Type: interventional Locations: Xiamen, Fujian, China

AZA Combined With RCHOP in P53-mutated DLBCL.

NCT ID: NCT06158399

This clinical trial is studying a new treatment approach for patients with a specific type of cancer called Diffuse Large B-cell Lymphoma (DLBCL), which is often associated with a mutation in a gen...

Recruiting

Phase: PHASE2 Type: interventional Locations: Xiamen, Fujian, China

CAR-T Followed by Bispecific Antibodies

NCT ID: NCT04889716

This clinical trial is looking at how safe and effective two new treatments, mosunetuzumab or a combination of obinutuzumab and glofitamab, are when given to patients who have already received CAR ...

Recruiting

Phase: PHASE2 Type: interventional Locations: Philadelphia, Pennsylvania, United States, Omaha, Nebraska, United States

Optimizing lymphoDepletion to Improve Outcomes In Patients Receiving Cell Therapy With Yescarta

NCT ID: NCT05950802

This clinical trial is studying a new approach to prepare patients with Diffuse Large B Cell Lymphoma (DLBCL) for a specific type of treatment called CAR T cell therapy. The goal is to find the bes...

Recruiting

Phase: PHASE1 Type: interventional Locations: Toronto, Ontario, Canada

AZA Combined with R-GemOx for Elderly DLBCL Patients

NCT ID: NCT06778902

This clinical trial is looking at a new treatment approach for elderly patients with diffuse large B-cell lymphoma (DLBCL), which is a type of blood cancer. The trial will study the safety and effe...

Not yet recruiting

Phase: PHASE2 Type: interventional Locations: Chongqing, , China

Study of a Communication Training Intervention for Large B-Cell Lymphoma Providers

NCT ID: NCT05940272

This clinical trial is focused on improving how doctors communicate with patients who have a type of cancer called large B-cell lymphoma, specifically a subtype known as diffuse large B-cell lympho...

Recruiting

Phase: NA Type: interventional Locations: New York, New York, United States, New York, New York, United States +1 more

Real-World Study of DLBCL With Different Genetic Subtypes

NCT ID: NCT06026488

This clinical trial is studying a type of cancer called Diffuse Large B Cell Lymphoma (DLBCL). The goal is to gather information about how well different treatments work for patients with various g...

Recruiting

Type: observational Locations: Shanghai, Shanghai, China

Comparison of Point-of-care Produced CAR T-cell with Commercial CAR T-cells in Patients with R/R LBCL

NCT ID: NCT05641428

This clinical trial is studying a new way to produce CAR T-cells, which are a type of treatment for certain blood cancers like relapsed or refractory diffuse large B-cell lymphoma (DLBCL). In this ...

Recruiting

Phase: PHASE2 Type: interventional Locations: Amsterdam, , Netherlands, Groningen, , Netherlands +5 more

Prevention of Anthracycline-Induced Cardiac Dysfunction With Dexrazoxane in Patients With Diffuse Large-B Cell Lymphoma

NCT ID: NCT06220032

This clinical trial, called ANTICIPATE, is looking at whether a medication called dexrazoxane can help prevent heart problems in patients being treated for Diffuse Large B-Cell Lymphoma (DLBCL). Pa...

Recruiting

Phase: PHASE3 Type: interventional Locations: Amstelveen, , Netherlands, Apeldoorn, , Netherlands +24 more

Low Dose Radiation as Bridging Therapy in Relapsed B-Cell Non-Hodgkin Lymphoma

NCT ID: NCT05621096

This clinical trial is studying the use of low-dose radiation therapy as a potential treatment for patients with certain types of B-cell lymphoma that have either not responded to previous treatmen...

Recruiting

Phase: PHASE1 Type: interventional Locations: Omaha, Nebraska, United States

Milaberon in Advanced Solid Tumors: an Open, Multicenter Clinical Study

NCT ID: NCT06534762

This clinical trial is investigating a medication called Milaberon in patients with advanced solid tumors, including lung cancer, colorectal cancer, pancreatic cancer, triple-negative breast cancer...

Recruiting

Phase: PHASE2 Type: interventional Locations: Hangzhou, Zhejiang, China, Hangzhou, Zhejiang, China

Molecular Mechanisms in Malignant Lymphoma- Predict (MMML Predict)

NCT ID: NCT06526065

The MMML Predict trial is studying a new tool that can help doctors better understand how likely it is for patients with Diffuse Large B Cell Lymphoma (DLBCL) to respond to their initial treatment....

Recruiting

Type: observational Locations: Göttingen, Lower Saxony, Germany

Epcoritamab (Epcor)-Containing Combination Salvage Therapy Followed by ASCT & Epcor Consolidation in Patients With Relapsed LBCL

NCT ID: NCT06287398

This clinical trial is studying a new treatment approach for patients with relapsed or difficult-to-treat aggressive B-cell lymphomas, such as Diffuse Large B-cell Lymphoma (DLBCL). The trial is te...

Recruiting

Phase: PHASE2 Type: interventional Locations: Melbourne, Victoria, Australia

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions